IL103304A - Carbamate derivatives of 3-isoxazolidinones hydroxypyrrolidin-2-ones and cyclopropanecarboxylic acid analogs a process for their preparation and their use as medicaments - Google Patents

Carbamate derivatives of 3-isoxazolidinones hydroxypyrrolidin-2-ones and cyclopropanecarboxylic acid analogs a process for their preparation and their use as medicaments

Info

Publication number
IL103304A
IL103304A IL10330492A IL10330492A IL103304A IL 103304 A IL103304 A IL 103304A IL 10330492 A IL10330492 A IL 10330492A IL 10330492 A IL10330492 A IL 10330492A IL 103304 A IL103304 A IL 103304A
Authority
IL
Israel
Prior art keywords
compound
hydrogen
loweralkyl
formula
carbamate
Prior art date
Application number
IL10330492A
Other languages
English (en)
Other versions
IL103304A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL103304A0 publication Critical patent/IL103304A0/xx
Publication of IL103304A publication Critical patent/IL103304A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
IL10330492A 1991-10-01 1992-09-30 Carbamate derivatives of 3-isoxazolidinones hydroxypyrrolidin-2-ones and cyclopropanecarboxylic acid analogs a process for their preparation and their use as medicaments IL103304A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/769,268 US5153193A (en) 1991-10-01 1991-10-01 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

Publications (2)

Publication Number Publication Date
IL103304A0 IL103304A0 (en) 1993-02-21
IL103304A true IL103304A (en) 1996-12-05

Family

ID=25084962

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10330492A IL103304A (en) 1991-10-01 1992-09-30 Carbamate derivatives of 3-isoxazolidinones hydroxypyrrolidin-2-ones and cyclopropanecarboxylic acid analogs a process for their preparation and their use as medicaments

Country Status (21)

Country Link
US (1) US5153193A (de)
EP (2) EP0535645B1 (de)
JP (1) JP2703157B2 (de)
KR (2) KR100276143B1 (de)
AT (1) ATE201024T1 (de)
AU (1) AU649882B2 (de)
CA (1) CA2079548C (de)
CZ (1) CZ281982B6 (de)
DE (1) DE69231817T2 (de)
DK (1) DK0535645T3 (de)
ES (1) ES2157201T3 (de)
FI (2) FI102178B (de)
GR (1) GR3036334T3 (de)
HU (1) HU215120B (de)
IL (1) IL103304A (de)
MX (1) MX9205577A (de)
NO (1) NO301884B1 (de)
NZ (1) NZ244540A (de)
PT (1) PT535645E (de)
RU (1) RU2103271C1 (de)
TW (1) TW208009B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231093A (en) * 1991-10-01 1993-07-27 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
IT1253007B (it) * 1991-12-31 1995-07-10 Aesculapius Farma Srl Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
US6316439B1 (en) 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
WO2000059544A1 (en) * 1999-03-31 2000-10-12 Eisai Co., Ltd. Stabilized compositions containing nootropic drugs
RU2241001C2 (ru) * 2000-03-31 2004-11-27 Санохемиа Фармацойтика Акциенгезелльшафт Производные галантамина, способ их получения, лекарственное средство на их основе и способ его получения
JP2004522711A (ja) * 2000-11-16 2004-07-29 アルコン マニュファクチャリング，リミティド 眼内圧の低下および制御のための組み合わせ治療
AU2004285893B2 (en) * 2003-10-21 2011-12-15 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US7549431B1 (en) * 2004-11-10 2009-06-23 Gore Enterprise Holdings, Inc. Protective enclosure
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1974782U (de) 1967-07-04 1967-12-14 Filzfabrik Fulda G M B H & Co Matratzenschoner.
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
ATE411026T1 (de) * 1987-05-04 2008-10-15 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
GB8727792D0 (en) * 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
GB8823605D0 (en) * 1988-10-07 1988-11-16 Merck Sharp & Dohme Therapeutic agents
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5061721A (en) * 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
JPH05194519A (ja) 1993-08-03
NO301884B1 (no) 1997-12-22
HU215120B (hu) 1998-09-28
CZ281982B6 (cs) 1997-04-16
DK0535645T3 (da) 2001-08-13
FI924370A7 (fi) 1993-04-02
KR930007947A (ko) 1993-05-20
ES2157201T3 (es) 2001-08-16
DE69231817D1 (de) 2001-06-13
NO923803L (no) 1993-04-02
DE69231817T2 (de) 2001-09-27
FI102178B1 (fi) 1998-10-30
EP1069125A3 (de) 2001-10-10
KR100276143B1 (ko) 2001-03-02
NZ244540A (en) 1995-04-27
IL103304A0 (en) 1993-02-21
FI981710A0 (fi) 1998-08-06
US5153193A (en) 1992-10-06
PT535645E (pt) 2001-09-27
CA2079548C (en) 2002-03-19
FI924370A0 (fi) 1992-09-29
TW208009B (de) 1993-06-21
FI981710A7 (fi) 1998-08-06
AU649882B2 (en) 1994-06-02
RU2103271C1 (ru) 1998-01-27
EP0535645A3 (en) 1993-08-04
JP2703157B2 (ja) 1998-01-26
FI102178B (fi) 1998-10-30
EP0535645B1 (de) 2001-05-09
ATE201024T1 (de) 2001-05-15
HU9203129D0 (en) 1992-12-28
KR100271416B1 (en) 2000-11-15
FI981710L (fi) 1998-08-06
CA2079548A1 (en) 1993-04-02
AU2606592A (en) 1993-04-08
EP1069125A2 (de) 2001-01-17
NO923803D0 (no) 1992-09-30
GR3036334T3 (en) 2001-11-30
MX9205577A (es) 1993-04-01
CZ299092A3 (en) 1993-10-13
EP0535645A2 (de) 1993-04-07
HUT65277A (en) 1994-05-02

Similar Documents

Publication Publication Date Title
US5153193A (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5231093A (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5106856A (en) [(Arylalkylpiperidin-4-yl)methyl]-2a,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-ones and related compounds
US5100891A (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
US5264442A (en) Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5234941A (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5173497A (en) Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
JP3042902B2 (ja) ヘキサヒドロピロロ〔２，３−ｂ〕インドールカルバメート、−尿素、−アミドおよび関連化合物
EP0471296B1 (de) 1-(Pyridinylalkyl)-1H-indole, -indoline und Analoge
US5264587A (en) Method of preparing α-oxopyrrolo[2,3-b]indole acetic acids and derivatives
NZ260210A (en) Pyrrolo[2,3-b]indole acetic acids and pharmaceutical compositions
US5214058A (en) 1-(pyridinylalkyl)-1H-indoles, indolines and related analogs

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
RH Patent void
RH1 Patent not in force